Trade ALVO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Alvotech (ALVO) is trading at US$4.95, up 1.43% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$1.5B. Over the past 52 weeks, ALVO has traded between US$2.94 and US$9.25. On Syfe you can trade ALVO with $0 commission and add it to your watchlist.
| Previous close | US$4.88 |
|---|---|
| Market cap | US$1.5B |
| P/E ratio | 34.20 |
| 52-week range | US$2.94 – US$9.25 |
| Volume | 875.33K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alvotech
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Year: 2022
Alvotech Faces 'Soft' Q2 but Well Positioned to Benefit From Upcoming Biosimilar Opportunity, UBS Says
Jul 6, 7:21 PM · MT Newswires
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of Fed Chair Warsh's International Debut
Jul 1, 12:38 PM · MT Newswires
Alvotech (ALVO) stock is trading at US$4.95, +1.43% from the previous close of US$4.88.
The market cap for Alvotech (ALVO) stock is approximately US$1.5B.
The price-to-earnings ratio for Alvotech (ALVO) is 34.20, based on the latest reported earnings.
The 52-week high for Alvotech (ALVO) stock is US$9.25.
The 52-week low for Alvotech (ALVO) stock is US$2.94.
Alvotech (ALVO) does not currently pay a dividend.
Stay on top of ALVO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
